N-(1,3-benzodioxol-5-yl)-6-(3,5-dimethyl-1,2-oxazol-4-yl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(3-fluoro-4-methoxyphenyl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(4-methoxyphenyl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(6-methoxy-3-pyridinyl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(4-methylphenyl)pyrazin-2-amine;2-(4-methylanilino)-6-(2-methylbenzimidazol-1-yl)pyridine-4-carbonitrile

C100H93FN26O10 — CID 159952192

IUPACN-(1,3-benzodioxol-5-yl)-6-(3,5-dimethyl-1,2-oxazol-4-yl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(3-fluoro-4-methoxyphenyl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(4-methoxyphenyl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(6-methoxy-3-pyridinyl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(4-methylphenyl)pyrazin-2-amine;2-(4-methylanilino)-6-(2-methylbenzimidazol-1-yl)pyridine-4-carbonitrile
SMILESCOc1ccc(Nc2cncc(-c3c(C)noc3C)n2)cc1.COc1ccc(Nc2cncc(-c3c(C)noc3C)n2)cc1F.COc1ccc(Nc2cncc(-c3c(C)noc3C)n2)cn1.Cc1ccc(Nc2cc(C#N)cc(-n3c(C)nc4ccccc43)n2)cc1.Cc1ccc(Nc2cncc(-c3c(C)noc3C)n2)cc1.Cc1noc(C)c1-c1cncc(Nc2ccc3c(c2)OCO3)n1
InChIInChI=1S/C21H17N5.C16H15FN4O2.C16H14N4O3.C16H16N4O2.C16H16N4O.C15H15N5O2/c1-14-7-9-17(10-8-14)24-20-11-16(13-22)12-21(25-20)26-15(2)23-18-5-3-4-6-19(18)26;1-9-16(10(2)23-21-9)13-7-18-8-15(20-13)19-11-4-5-14(22-3)12(17)6-11;1-9-16(10(2)23-20-9)12-6-17-7-15(19-12)18-11-3-4-13-14(5-11)22-8-21-13;1-10-16(11(2)22-20-10)14-8-17-9-15(19-14)18-12-4-6-13(21-3)7-5-12;1-10-4-6-13(7-5-10)18-15-9-17-8-14(19-15)16-11(2)20-21-12(16)3;1-9-15(10(2)22-20-9)12-7-16-8-13(19-12)18-11-4-5-14(21-3)17-6-11/h3-12H,1-2H3,(H,24,25);4-8H,1-3H3,(H,19,20);3-7H,8H2,1-2H3,(H,18,19);4-9H,1-3H3,(H,18,19);4-9H,1-3H3,(H,18,19);4-8H,1-3H3,(H,18,19)
InChIKeyOCGJWOXPESLKCN-UHFFFAOYSA-N
MW1838.01 g/mol
LogP21.71
Rot. Bonds21

About N-(1,3-benzodioxol-5-yl)-6-(3,5-dimethyl-1,2-oxazol-4-yl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(3-fluoro-4-methoxyphenyl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(4-methoxyphenyl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(6-methoxy-3-pyridinyl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(4-methylphenyl)pyrazin-2-amine;2-(4-methylanilino)-6-(2-methylbenzimidazol-1-yl)pyridine-4-carbonitrile

N-(1,3-benzodioxol-5-yl)-6-(3,5-dimethyl-1,2-oxazol-4-yl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(3-fluoro-4-methoxyphenyl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(4-methoxyphenyl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(6-methoxy-3-pyridinyl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(4-methylphenyl)pyrazin-2-amine;2-(4-methylanilino)-6-(2-methylbenzimidazol-1-yl)pyridine-4-carbonitrile (PubChem CID 159952192) has the molecular formula C100H93FN26O10 and a molecular weight of 1838.01 g/mol. Its IUPAC name is N-(1,3-benzodioxol-5-yl)-6-(3,5-dimethyl-1,2-oxazol-4-yl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(3-fluoro-4-methoxyphenyl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(4-methoxyphenyl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(6-methoxy-3-pyridinyl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(4-methylphenyl)pyrazin-2-amine;2-(4-methylanilino)-6-(2-methylbenzimidazol-1-yl)pyridine-4-carbonitrile.

Molecular Properties

Compound NameN-(1,3-benzodioxol-5-yl)-6-(3,5-dimethyl-1,2-oxazol-4-yl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(3-fluoro-4-methoxyphenyl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(4-methoxyphenyl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(6-methoxy-3-pyridinyl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(4-methylphenyl)pyrazin-2-amine;2-(4-methylanilino)-6-(2-methylbenzimidazol-1-yl)pyridine-4-carbonitrile
PubChem CID159952192
Molecular FormulaC100H93FN26O10
Molecular Weight1838.01 g/mol
Exact Mass1836.76
IUPAC NameN-(1,3-benzodioxol-5-yl)-6-(3,5-dimethyl-1,2-oxazol-4-yl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(3-fluoro-4-methoxyphenyl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(4-methoxyphenyl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(6-methoxy-3-pyridinyl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(4-methylphenyl)pyrazin-2-amine;2-(4-methylanilino)-6-(2-methylbenzimidazol-1-yl)pyridine-4-carbonitrile
SMILESCOc1ccc(Nc2cncc(-c3c(C)noc3C)n2)cc1.COc1ccc(Nc2cncc(-c3c(C)noc3C)n2)cc1F.COc1ccc(Nc2cncc(-c3c(C)noc3C)n2)cn1.Cc1ccc(Nc2cc(C#N)cc(-n3c(C)nc4ccccc43)n2)cc1.Cc1ccc(Nc2cncc(-c3c(C)noc3C)n2)cc1.Cc1noc(C)c1-c1cncc(Nc2ccc3c(c2)OCO3)n1
InChIInChI=1S/C21H17N5.C16H15FN4O2.C16H14N4O3.C16H16N4O2.C16H16N4O.C15H15N5O2/c1-14-7-9-17(10-8-14)24-20-11-16(13-22)12-21(25-20)26-15(2)23-18-5-3-4-6-19(18)26;1-9-16(10(2)23-21-9)13-7-18-8-15(20-13)19-11-4-5-14(22-3)12(17)6-11;1-9-16(10(2)23-20-9)12-6-17-7-15(19-12)18-11-3-4-13-14(5-11)22-8-21-13;1-10-16(11(2)22-20-10)14-8-17-9-15(19-14)18-12-4-6-13(21-3)7-5-12;1-10-4-6-13(7-5-10)18-15-9-17-8-14(19-15)16-11(2)20-21-12(16)3;1-9-15(10(2)22-20-9)12-7-16-8-13(19-12)18-11-4-5-14(21-3)17-6-11/h3-12H,1-2H3,(H,24,25);4-8H,1-3H3,(H,19,20);3-7H,8H2,1-2H3,(H,18,19);4-9H,1-3H3,(H,18,19);4-9H,1-3H3,(H,18,19);4-8H,1-3H3,(H,18,19)
InChIKeyOCGJWOXPESLKCN-UHFFFAOYSA-N
XLogP21.71
TPSA444.77 Ų
H-Bond Donors6
H-Bond Acceptors36
Rotatable Bonds21
Heavy Atoms137
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001838.01
LogP ≤ 521.71
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1036

Analyze N-(1,3-benzodioxol-5-yl)-6-(3,5-dimethyl-1,2-oxazol-4-yl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(3-fluoro-4-methoxyphenyl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(4-methoxyphenyl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(6-methoxy-3-pyridinyl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(4-methylphenyl)pyrazin-2-amine;2-(4-methylanilino)-6-(2-methylbenzimidazol-1-yl)pyridine-4-carbonitrile with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-(1,3-benzodioxol-5-yl)-6-(3,5-dimethyl-1,2-oxazol-4-yl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(3-fluoro-4-methoxyphenyl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(4-methoxyphenyl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(6-methoxy-3-pyridinyl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(4-methylphenyl)pyrazin-2-amine;2-(4-methylanilino)-6-(2-methylbenzimidazol-1-yl)pyridine-4-carbonitrile?
The IUPAC name of N-(1,3-benzodioxol-5-yl)-6-(3,5-dimethyl-1,2-oxazol-4-yl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(3-fluoro-4-methoxyphenyl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(4-methoxyphenyl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(6-methoxy-3-pyridinyl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(4-methylphenyl)pyrazin-2-amine;2-(4-methylanilino)-6-(2-methylbenzimidazol-1-yl)pyridine-4-carbonitrile (CID 159952192) is N-(1,3-benzodioxol-5-yl)-6-(3,5-dimethyl-1,2-oxazol-4-yl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(3-fluoro-4-methoxyphenyl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(4-methoxyphenyl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(6-methoxy-3-pyridinyl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(4-methylphenyl)pyrazin-2-amine;2-(4-methylanilino)-6-(2-methylbenzimidazol-1-yl)pyridine-4-carbonitrile.
What is the SMILES notation for N-(1,3-benzodioxol-5-yl)-6-(3,5-dimethyl-1,2-oxazol-4-yl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(3-fluoro-4-methoxyphenyl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(4-methoxyphenyl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(6-methoxy-3-pyridinyl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(4-methylphenyl)pyrazin-2-amine;2-(4-methylanilino)-6-(2-methylbenzimidazol-1-yl)pyridine-4-carbonitrile?
The canonical SMILES for N-(1,3-benzodioxol-5-yl)-6-(3,5-dimethyl-1,2-oxazol-4-yl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(3-fluoro-4-methoxyphenyl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(4-methoxyphenyl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(6-methoxy-3-pyridinyl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(4-methylphenyl)pyrazin-2-amine;2-(4-methylanilino)-6-(2-methylbenzimidazol-1-yl)pyridine-4-carbonitrile is COc1ccc(Nc2cncc(-c3c(C)noc3C)n2)cc1.COc1ccc(Nc2cncc(-c3c(C)noc3C)n2)cc1F.COc1ccc(Nc2cncc(-c3c(C)noc3C)n2)cn1.Cc1ccc(Nc2cc(C#N)cc(-n3c(C)nc4ccccc43)n2)cc1.Cc1ccc(Nc2cncc(-c3c(C)noc3C)n2)cc1.Cc1noc(C)c1-c1cncc(Nc2ccc3c(c2)OCO3)n1.
What is the InChIKey of N-(1,3-benzodioxol-5-yl)-6-(3,5-dimethyl-1,2-oxazol-4-yl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(3-fluoro-4-methoxyphenyl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(4-methoxyphenyl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(6-methoxy-3-pyridinyl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(4-methylphenyl)pyrazin-2-amine;2-(4-methylanilino)-6-(2-methylbenzimidazol-1-yl)pyridine-4-carbonitrile?
The InChIKey is OCGJWOXPESLKCN-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H17N5.C16H15FN4O2.C16H14N4O3.C16H16N4O2.C16H16N4O.C15H15N5O2/c1-14-7-9-17(10-8-14)24-20-11-16(13-22)12-21(25-20)26-15(2)23-18-5-3-4-6-19(18)26;1-9-16(10(2)23-21-9)13-7-18-8-15(20-13)19-11-4-5-14(22-3)12(17)6-11;1-9-16(10(2)23-20-9)12-6-17-7-15(19-12)18-11-3-4-13-14(5-11)22-8-21-13;1-10-16(11(2)22-20-10)14-8-17-9-15(19-14)18-12-4-6-13(21-3)7-5-12;1-10-4-6-13(7-5-10)18-15-9-17-8-14(19-15)16-11(2)20-21-12(16)3;1-9-15(10(2)22-20-9)12-7-16-8-13(19-12)18-11-4-5-14(21-3)17-6-11/h3-12H,1-2H3,(H,24,25);4-8H,1-3H3,(H,19,20);3-7H,8H2,1-2H3,(H,18,19);4-9H,1-3H3,(H,18,19);4-9H,1-3H3,(H,18,19);4-8H,1-3H3,(H,18,19).
What are the key properties of N-(1,3-benzodioxol-5-yl)-6-(3,5-dimethyl-1,2-oxazol-4-yl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(3-fluoro-4-methoxyphenyl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(4-methoxyphenyl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(6-methoxy-3-pyridinyl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(4-methylphenyl)pyrazin-2-amine;2-(4-methylanilino)-6-(2-methylbenzimidazol-1-yl)pyridine-4-carbonitrile?
N-(1,3-benzodioxol-5-yl)-6-(3,5-dimethyl-1,2-oxazol-4-yl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(3-fluoro-4-methoxyphenyl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(4-methoxyphenyl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(6-methoxy-3-pyridinyl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(4-methylphenyl)pyrazin-2-amine;2-(4-methylanilino)-6-(2-methylbenzimidazol-1-yl)pyridine-4-carbonitrile has a molecular weight of 1838.01 g/mol, XLogP of 21.71, 21 rotatable bonds, 6 hydrogen bond donors, and 36 hydrogen bond acceptors.
Where does this data come from?
All data for N-(1,3-benzodioxol-5-yl)-6-(3,5-dimethyl-1,2-oxazol-4-yl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(3-fluoro-4-methoxyphenyl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(4-methoxyphenyl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(6-methoxy-3-pyridinyl)pyrazin-2-amine;6-(3,5-dimethyl-1,2-oxazol-4-yl)-N-(4-methylphenyl)pyrazin-2-amine;2-(4-methylanilino)-6-(2-methylbenzimidazol-1-yl)pyridine-4-carbonitrile is sourced from PubChem (CID 159952192), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).